|
| | 5 | Pharmacogenomics: The Implementation Phase Wolfgang Sadee | | 6 | Novel System to Investigate the Effects of Inhaled Volume and Rates of Rise in Simulated Inspiratory Air Flow on Fine Particle Output From a Dry Powder Inhaler Varsha Chavan, Richard Dalby | | 7 | Assuring Quality and Performance of Sustained and Controlled Release Parenterals: Workshop Report Diane J. Burgess, Ajaz S. Hussain, Thomas S. Ingallinera, Mei-Ling Chen | | 8 | Pharmacologic and Pharmacokinetic Profile of Repifermin (KGF-2) in Monkeys and Comparative Pharmacokinetics in Humans Cynthia Sung, Tom J. Parry, Todd A. Riccobene, Angela Mahoney, Viktor Roschke, James Murray, Mi Li Gu, Jeffrey K. Glenn, Florence Caputo, Cindy Farman, Daniel J. Odenheimer | | 9 | Is Antisense an Appropriate Nomenclature or Design for Oligodeoxynucleotides Aimed at the Inhibition of HIV-1 Replication? Carole Lavigne, Jocelyn Yelle, Gilles Sauvé, Alain R. Thierry | | 10 | cDNA Microarray Analysis of Vascular Gene Expression After Nitric Oxide Donor Infusions in Rats: Implications for Nitrate Tolerance Mechanisms Ellen Q. Wang, Woo-In Lee, Daniel Brazeau, Ho-Leung Fung | | 11 | Influence of Fluoxetine on Olanzapine Pharmacokinetics Denis Gossen, Jean-Marie de Suray, Francois Vandenhende, Claude Onkelinx, Diamon Gangji |
|
For more papers in press, go to AAPSJ Pre-publications.
|